Presence of anti-nuclear antibodies is a risk factor for the appearance of anti-drug antibodies during infliximab or adalimumab therapy in patients with rheumatoid arthritis.

Mori, Ayano; Saito, Toshiharu; Takahashi, Miho; Shibata, Miho; Tsuji, Goh; Hatachi, Saori; Takahashi, Soshi; Kumagai, Shunichi

Mori, Ayano; Saito, Toshiharu; Takahashi, Miho; Shibata, Miho; Tsuji, Goh; Hatachi, Saori; Takahashi, Soshi; Kumagai, Shunichi.

Afiliação

Mori A; The Shinko Institute for Medical Research, Shinko Hospital, Kobe, Japan.
Saito T; The Shinko Institute for Medical Research, Shinko Hospital, Kobe, Japan.
Takahashi M; The Shinko Institute for Medical Research, Shinko Hospital, Kobe, Japan.
Shibata M; The Shinko Institute for Medical Research, Shinko Hospital, Kobe, Japan.
Tsuji G; The Center for Rheumatic Disease, Shinko Hospital, Kobe, Japan.
Hatachi S; The Center for Rheumatic Disease, Shinko Hospital, Kobe, Japan.
Takahashi S; The Shinko Institute for Medical Research, Shinko Hospital, Kobe, Japan.
Kumagai S; The Center for Rheumatic Disease, Shinko Hospital, Kobe, Japan.

PLoS One ; 15(12): e0243729, 2020.

Article em En | MEDLINE | ID: mdl-33315881

Assuntos

Adalimumab/imunologia; Anticorpos/imunologia; Antirreumáticos/imunologia; Artrite Reumatoide/tratamento farmacológico; Etanercepte/imunologia; Infliximab/imunologia; Adalimumab/uso terapêutico; Adulto; Idoso; Anticorpos Antinucleares/imunologia; Antirreumáticos/uso terapêutico; Artrite Reumatoide/imunologia; Etanercepte/uso terapêutico; Feminino; Humanos; Infliximab/uso terapêutico; Masculino; Pessoa de Meia-Idade; Fator de Necrose Tumoral alfa/antagonistas & inibidores

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Adalimumab / Infliximab / Etanercepte / Anticorpos Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google